Abstract: The invention relates to sulfoximine-substituted pyrimidines of the general formula I processes for the preparation thereof and their use as drugs.

Abstract: A device for scaling and quantization of digital soft output values (sk) from an equalizer has a control loop for controlling a statistical parameter (?) for the scaled and quantized soft output values (sD,k), which contains a calculation unit (4) for calculation of the statistical parameter (?), and a control unit (5) for calculation of a scaling factor (c) for scaling the soft output values (sk) from the equalizer on the basis of the statistical parameter (?).

Abstract: In order to compensate for a frequency offset or a change in the phase of the transmission channel over time during mobile radio transmission of data symbols, the data symbols are transmitted by way of carrier-frequency, modulated data bursts. Sample values of the received signal, which are known in advance and correspond to first and second symbols, are evaluated in order to estimate the frequency offset or the change in the phase of the transmission channel over time. These first and second symbols are transmitted with a defined phase angle by way of the data burst, and are arranged separated from one another in the data burst. Edge symbols in a data burst are advantageously used as first and second symbols, or as a symbol pair, for estimation.

Abstract: This invention relates to pyrimidine derivatives of general formula I in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, as inhibitors of cyclin-dependent kinases and VEGF-receptor tyrosine kinases, their production as well as their use as medications for treatment of various diseases.

Abstract: VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. The compounds according to the invention can be used as or in the case of tumor or metastasis growth, psoriasis, Kaposi's sarcoma, restenosis, such as, e.g.

Abstract: The invention relates to a process for preparing an alcoholic solution of an alkali metal alkoxide from alkali metal hydroxide and alcohol in a reaction column, the alcohol and the alkali metal hydroxide being conducted in countercurrent, which is characterized in that a reflux ratio of at least is established in the reaction column.

Abstract: The proposed iterative method concurrently calculates maximum likelihood estimated values for the channel coefficients (h0, . . . , hL; ?h) and the DC offset (d; ?d) on the basis of a training sequence (TSC) in a TDMA mobile communications system. The SAGE algorithm leads to two recursion formulae, by means of which the iterative calculation of estimated values for the channel coefficients (h0, . . . , hL; ?h) and for the DC offset (d; ?d) is provided.

Abstract: A method for equalization of a signal is provided, wherein the equalization is of a signal that is transmitted via a data channel based on the DF method. The method takes account of at least one interference channel, and includes processing of at least two trellis diagrams in each time unit, with the states of at least one of the trellis diagrams describing the data channel. A DF contribution that is used for processing of this trellis diagram includes information about at least one interference channel.

Abstract: In a method for correlative estimation of a mobile radio channel on the basis of a training sequence (TS) which is transmitted via the mobile radio channel, a sequence of P received symbols is correlated with a subsequence of length P of the training sequence, in order to calculate a first estimated channel coefficient (?0(1)). Furthermore, the same sequence of P received symbols is correlated with at least some of the subsequences of the training sequence (TS) shifted through ±1, ±2, . . . , ±(Lt?1) symbol positions, in order to calculate a number of further estimated channel coefficients (?±1(1),?±2(1), . . . ,?±(Lt?1)(1)).

Abstract: This invention relates to 2-heteroaryl-pyrimidine derivatives of general formula I or If as inhibitors of the cyclin-dependent kinases, their production as well as their use as medications for treating various diseases.

Abstract: In a method to compensate for a step DC disturbance (1) in a baseband signal in a homodyne radio receiver, the time profile of the step DC disturbance within a burst is determined. In order to produce a step-corrected baseband signal, the determined time profile (2) is then calculated from the digitized baseband signal.

Abstract: The invention relates to sulfoximine-substituted pyrimidines of the general formula I processes for the preparation thereof and their use as drugs.

Abstract: VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. The compounds according to the invention can be used as or in the case of tumor or metastasis growth, psoriasis, Kaposi's sarcoma, restenosis, such as, e.g.

Abstract: Aza- and polyazanthranyl amides and their use as medicaments in the treatment of diseases caused by persistent angiogenesis are described, as well as the intermediates used in the preparation of the aza- and polyazanthranyl amides.

Abstract: VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. The compounds according to the invention can be used as or in the case of tumor or metastasis growth, psoriasis, Kaposi's sarcoma, restenosis, such as, e.g.

Abstract: The invention relates to anthranilic acid amides and the use thereof as medicaments for the treatment of diseases that are triggered by persistent angiogenesis, in addition to intermediate products in the production of anthranilic acid amides.

Abstract: Only a single, standard-independent clock rate is generated in a signal processor or a signal processing structure, and correspondingly only precisely one clock frequency generator is then arranged on the chip. The signal processing path includes at least one controllable, asynchronous decimator for transposing the reception signals present in a uniform time frame into a respective standard-specific time frame. This enables signals of a variety of mobile phone standards to be processed.

Abstract: In a method for error correcting a data signal that is transmitted via a channel and contains data blocks with associated error checking information, the data signal is first equalized, with calculated soft-bit information. In a subsequent step, the error checking information is evaluated with respect to the data block. If the evaluation of the error checking information shows that a single bit error is present in one message bit, the single bit error is corrected only when a condition that is dependent on the soft-bit information is satisfied.

Abstract: Described are compunds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10—(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is SO2; R1 is aryl; R2 is a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms with the exception that R2 cannot represent 2-phthalimidyl, and in case of Y?SO2 cannot represent 2,1,3-benzothiadiazol-4-yl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each, other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g. of a neoplastic disease, such as a tumor disease, of retinopathy and age-related macular degeneration.

Abstract: The proposed iterative method concurrently calculates maximum likelihood estimated values for the channel coefficients (h0, . . . , hL; ?h) and the DC offset (d; ?d) on the basis of a training sequence (TSC) in a TDMA mobile communications system. The SAGE algorithm leads to two recursion formulae, by means of which the iterative calculation of estimated values for the channel coefficients (ho, . . . , hL; ?h) and for the DC offset (d; ?d) is provided.